5 Possible New Ideas for Artificial Pancreas Technology:
We examine a federal policy shift that may affect the diabetes community. Policy News Watch On January 11th, Brian Neale, the director of the Center for Medicaid, sent out a letter to state Medicaid directors informing them that the Trump administration would allow states to impose work requirements for Medicaid recipients. The letter states that […]
Here are three ways the proposed tax overhaul might impact people with diabetes. It seems likely that a Republican-led bill to overhaul the U.S. tax code will pass the Senate; a similar tax overhaul bill has already passed the House of Representatives. If both bills pass, a conference between lawmakers of the two legislative bodies […]
What’s new in Glu Research? The Research Team is proud to announce that we are collaborating with Glu’s very own Dr. Nick on a survey! The survey investigates the effect The Centers for Medicare & Medicaid Services (CMS) policies might have on the lives of people with type 1 diabetes who are or were on pumps […]
Wrapping up our spotlight series on the patient panelists appearing at this week’s T1D Exchange Annual Meeting, we introduce Bunny Kasper. Bunny is an active diabetes advocate and JDRF volunteer from Hamden Connecticut. As a married mother of three sons and nine grandchildren (two of whom also have type 1 diabetes), Bunny was misdiagnosed for […]
As we get closer to the T1D Exchange Annual Meeting, which will take place on Tuesday, October 3rd, we’re introducing those who will sit on our patient panel at the start of the meeting. Earlier this week, we featured Sandy Brooks and Nick Argento, two active members of the Glu community. Our third panelist, Paul […]
Medtronic has become aware of recent reports of potential over-delivery of insulin shortly after an infusion set change. Over-delivery of insulin can cause hypoglycemia and in extreme cases, death. Medtronic has received reports of hypoglycemia requiring medical intervention potentially related to this issue. Are your MiniMed infusion sets part of the recall? We urge you […]
Background: Medicare was virtually the last large insurer not to cover CGM The type 1 diabetes community achieved a long sought and hard fought victory on January 12, 2017, when the Center for Medicare and Medicaid Services (CMS) announced that it would cover Continuous Glucose Monitoring (CGM). This came after a decision from the Food […]
When the type 1 community comes together, we’re louder, stronger, and more powerful. T1D Exchange is a unique nonprofit that combines our collective voices to demand better treatments and better care. This week, we are highlighting the various ways in which our community has made a difference…Together One. As the topic of health care dominates […]
Together We’re One: Fighting for Choice and Competition in the Marketplace When the type 1 community comes together, we’re louder, stronger, and more powerful. T1D Exchange is a unique nonprofit that combines our collective voices to demand better treatments and better care. This week, we are highlighting the various ways in which our community has […]
When the type 1 community comes together, we’re louder, stronger and more powerful. T1D Exchange is a unique nonprofit that combines our collective voices to demand better treatments and better care. This week, we are highlighting the various ways in which our community has made a difference…Together One. In early 2017, with a new administration […]
